Strategic Diagnostics appoints new CFO
This article was originally published in Clinica
Executive Summary
Custom antibody producer Strategic Diagnostics has appointed Kevin Bratton CFO and vice-president of finance. Before this, Mr Bratton was senior vice-president of business operations for EUSA Pharma, and previously to that, was senior vice-president and CFO of Cytogen, before it was acquired by EUSA Pharma in May 2008. He has over 35 years of experience in multinational financial operations across the healthcare, biotechnology and technology industries. Newark, Delaware-based Strategic Diagnostics provides monoclonal and polyclonal antibodies, and contract assay development services for the diagnostic and biotechnology markets, among others. It also manufactures kits for food safety, environmental and water quality testing.